Danimer Scientific, Inc.
General ticker "DNMR" information:
- Sector: Materials
- Industry: Chemicals
- Capitalization: $142.1M (TTM average)
Danimer Scientific, Inc. does not follow the US Stock Market performance with the rate: -4.2%.
Estimated limits based on current volatility of 0.0%: low 0.35$, high 0.35$
Factors to consider:
- Total employees count: 257 (-5.2%) as of 2023
- US accounted for 95.1% of revenue in the fiscal year ended 2023-12-31
- Top business risk factors: Limited commercialization experience, Market acceptance, Regulatory and compliance, Need for additional capital, Liquidity and credit risks
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [17.83$, 61.72$]
- 2024-12-30 to 2025-12-30 estimated range: [10.75$, 38.59$]
Financial Metrics affecting the DNMR estimates:
- Negative: with PPE of -0.7 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -1.14 <= 0.33
- Negative: negative Net income
- Positive: 18.93 < Shareholder equity ratio, % of 39.82 <= 41.86
- Positive: Inventory ratio change, % of -3.62 <= -0.75
- Negative: Industry operating profit margin (median), % of 4.45 <= 9.92
Short-term DNMR quotes
Long-term DNMR plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $58.67MM | $53.22MM | $46.44MM |
| Operating Expenses | $158.14MM | $240.65MM | $172.06MM |
| Operating Income | $-99.47MM | $-187.43MM | $-125.62MM |
| Non-Operating Income | $26.13MM | $6.87MM | $-29.54MM |
| Interest Expense | $0.76MM | $1.72MM | $29.64MM |
| R&D Expense | $20.27MM | $31.94MM | $29.24MM |
| Income(Loss) | $-73.34MM | $-180.57MM | $-155.15MM |
| Taxes | $-13.23MM | $-0.81MM | $0.32MM |
| Profit(Loss)* | $-60.11MM | $-179.76MM | $-155.47MM |
| Stockholders Equity | $500.26MM | $377.61MM | $278.02MM |
| Inventory | $24.57MM | $32.74MM | $25.27MM |
| Assets | $838.60MM | $712.27MM | $698.13MM |
| Operating Cash Flow | $-62.96MM | $-61.84MM | $-47.26MM |
| Capital expenditure | $185.41MM | $164.49MM | $27.68MM |
| Investing Cash Flow | $-336.17MM | $-182.48MM | $-27.66MM |
| Financing Cash Flow | $306.20MM | $21.75MM | $84.03MM |
| Earnings Per Share** | $-0.65 | $-1.78 | $-1.52 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.